NDC 75834-040
Nivanex DMX
Guaifenesin, Dextromethorphan Hydrobromide, And Phenylephrine Hydrochloride
Nivanex DMX is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Nivagen Pharmaceuticals, Inc.. The primary component is Guaifenesin; Dextromethorphan Hydrobromide; Phenylephrine Hydrochloride.
| Product ID | 75834-040_01de242b-aaed-4b85-ae6b-b9d90d8f1d41 |
| NDC | 75834-040 |
| Product Type | Human Otc Drug |
| Proprietary Name | Nivanex DMX |
| Generic Name | Guaifenesin, Dextromethorphan Hydrobromide, And Phenylephrine Hydrochloride |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-11-24 |
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Labeler Name | Nivagen Pharmaceuticals, Inc. |
| Substance Name | GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE |
| Active Ingredient Strength | 380 mg/1; mg/1; mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |